Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PC-1005 Gel for HIV Prevention in Women
NCT02033109Phase 1Completed
- Sponsor
- Population Council
- Start
- May 2014
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of MIV-150 in human immunodeficiency virus infection (HIV) (3 arms), sponsored by Population Council. Primary endpoint: Adverse events, serious adverse events, physical exams, and clinical laboratory parameters. Started May 2014; status: completed.
02
Drugs
MIV-150
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02033109.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02033109.